Stocktoria

Warby Parker Inc. WRBY

NYSE · XNYS · stock · Ophthalmic Goods · website · IPO 2021-09-29

Warby Parker Inc. financials (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Revenue$871.9M$771.3M$669.8M$598.1M$540.8M
Gross profit$470.6M$426.8M$365.2M$341.1M$317.7M
SG&A expense$475.9M$456.9M$437.2M$452.3M$461.4M
Operating income-$5.3M-$30.1M-$72.0M-$111.2M-$143.7M
Income tax$1.4M$875,000$433,000$497,000$263,000
Net income$1.6M-$20.4M-$63.2M-$110.4M-$144.3M
EPS (diluted)$0.01$-0.17$-0.54$-0.96$-2.21
Operating cash flow$110.8M$98.7M$61.0M$10.4M-$32.0M
Free cash flow$43.7M$34.7M$7.3M-$49.8M-$80.5M
Cash & equivalents$286.4M$254.2M$216.9M$208.6M$256.4M
Inventory$44.5M$52.3M$62.2M$68.8M$57.1M
Total assets$720.9M$676.5M$580.3M$568.7M$440.6M
Total liabilities$353.2M$336.4M$278.5M$282.1M$154.6M
Shareholders' equity$367.7M$340.1M$301.8M$286.6M$286.0M

Source: SEC EDGAR filings · CIK 0001504776 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.